Clene CLNN
NASDAQ CLNN
$3.65 -0.07 (-1.88%)
At close: Sep 10, 2026 · 4:00 PM EDT

Clene (CLNN) Non-Current Assets (2019 - 2026)

Clene (CLNN) posted Non-Current Assets of $8.1 million for Q2 2026, down 11.22% on a QoQ basis from $9.2 million in Q4 2025, and down 19.85% year-over-year from $10.1 million in Q2 2025.

Analysis

Clene (CLNN) Non-Current Assets (2019 - 2026) Analysis & Trends

Clene has reported Non-Current Assets for 8 years, with the latest figure at $8.1 million in Q2 2026.

  • On a quarterly basis, Non-Current Assets fell 19.85% year-over-year to $8.1 million in Q2 2026; TTM through Jun 2026 was $37.1 million, a 15.46% decrease from a year earlier, with the FY2025 full-year figure at $9.2 million, down 18.12% from the prior year.
  • Non-Current Assets was $8.1 million for Q2 2026 at Clene, down from $9.2 million in the prior quarter.
  • The five-year high for Non-Current Assets was $15.3 million in Q4 2022, with the low at $8.1 million in Q2 2026.
  • Average Non-Current Assets over 5 years is $12.2 million, with a median of $12.4 million recorded in 2024.
  • The sharpest annual moves came in 2022 and 2026: Non-Current Assets surged 152.73% in 2022, then retreated 19.85% in 2026.
  • Over 5 years, Non-Current Assets stood at $15.3 million in 2022, then retreated by 11.83% to $13.5 million in 2023, then fell by 17.12% to $11.2 million in 2024, then retreated by 18.12% to $9.2 million in 2025, then fell by 11.22% to $8.1 million in 2026.
  • The last three Non-Current Assets figures came in at $8.1 million (Q2 2026), $9.2 million (Q4 2025), and $9.6 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 141.29 Bn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 101.45 Bn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 94.68 Bn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn 159.77 Bn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 113.37 Bn
7 Revolution Medicines 42.88 Bn 42.88 Bn - 294.93 Mn
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 1.85 Bn
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 3.74 Bn
10 Clene 45.69 Mn 45.69 Mn 54,000.00 8.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.13 Mn
Dec 31, 2025 9.15 Mn
Sep 30, 2025 9.64 Mn
Jun 30, 2025 10.14 Mn
Mar 31, 2025 10.64 Mn
Dec 31, 2024 11.18 Mn
Sep 30, 2024 11.87 Mn
Jun 30, 2024 12.42 Mn
Mar 31, 2024 12.96 Mn
Dec 31, 2023 13.49 Mn
Sep 30, 2023 13.99 Mn
Jun 30, 2023 14.47 Mn
Mar 31, 2023 15.07 Mn
Dec 31, 2022 15.30 Mn
Sep 30, 2022 14.52 Mn
Jun 30, 2022 12.96 Mn
Mar 31, 2022 10.91 Mn
Dec 31, 2021 8.48 Mn
Sep 30, 2021 7.64 Mn
Jun 30, 2021 5.13 Mn